Macrogenics (MGNX) Payables (2012 - 2026)

Macrogenics (MGNX) has 15 years of Payables data on file, last reported at $4.3 million in Q1 2026.

• Payables for Q1 2026 came in at $4.3 million, down 35.21% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.3 million (down 35.21% YoY), and the FY2025 annual result was $4.8 million, down 4.51% from the prior year.
• Payables eased to $4.3 million in Q1 2026 per MGNX's latest filing, from $4.8 million in the prior quarter.
• Over five years, Payables peaked at $10.7 million in Q1 2024 and troughed at $2.6 million in Q2 2022.
• A 5-year average of $5.1 million and a median of $4.8 million in 2025 frame the typical range for Payables.
• The sharpest annual moves came in 2022 and 2024: Payables tumbled 73.43% in 2022, then jumped 184.49% in 2024.
• A 5-year view of Payables shows it stood at $4.9 million in 2022, then jumped by 31.52% to $6.4 million in 2023, then retreated by 22.19% to $5.0 million in 2024, then fell by 4.51% to $4.8 million in 2025, then decreased by 10.44% to $4.3 million in 2026.
• Business Quant data shows MGNX's Payables at $4.3 million in Q1 2026, $4.8 million in Q4 2025, and $5.9 million in Q3 2025.